Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Alunbrig

PharmaCompass

01

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 61

2018 Revenue in Millions : 147

Growth (%) : -58

blank

02

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 82

2019 Revenue in Millions : 63

Growth (%) : 30

blank

03

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 105

2020 Revenue in Millions : 78

Growth (%) : 44

blank

04

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 149

2021 Revenue in Millions : 105

Growth (%) : 42

blank

05

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 177

2022 Revenue in Millions : 149

Growth (%) : 34

blank

06

Brand Name : Alunbrig

Brigatinib

arrow
Pharmex
Not Confirmed

Brand Name : Alunbrig

arrow
Pharmex
Not Confirmed

Brigatinib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 238

2023 Revenue in Millions : 176

Growth (%) : 35

blank